• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于头颅计算机断层扫描的定量造影剂剂量评估

Quantitative contrast media dose evaluation for cranial computed tomography.

作者信息

Hammer G M, Kuhn M J, Meis D M, Meis L C

机构信息

Division of Neuroradiology, Southern Illinois University School of Medicine, Springfield 62769, USA.

出版信息

Comput Med Imaging Graph. 1995 May-Jun;19(3):287-93. doi: 10.1016/0895-6111(95)00006-c.

DOI:10.1016/0895-6111(95)00006-c
PMID:7641173
Abstract

The goal of this study was to quantitatively evaluate the CT enhancement characteristics of selected intracranial blood vessels using four different volumes of a contrast medium under otherwise identical conditions in order to help determine a cost-effective dose. In a double blind, prospective manner, 100 patients referred for contrast-enhanced cranial CT were randomly assigned to receive one of four different volumes (50, 75, 100 or 120 ml) of ioversol 320 mg I/ml which was subsequently administered intravenously at a rate of 1 ml/s via a power injector. Unenhanced images were also obtained. Scanning times, slice thickness and other parameters were identical in all patients. Scanning was initiated immediately following delivery of the full volume of contrast. Region of interest Hounsfield unit measurements were acquired in a standardized manner using a 1 mm diameter circle on the pre- and post-contrast scans of the supraclinoid left internal carotid artery (LICA), supraclinoid right internal carotid artery (RICA), basilar artery (BA), and torcular region (TR). The mean enhancement value (in Hounsfield units) for the 50 ml, 75 ml, 100 ml and 120 ml dose groups respectively were as follows for each vessel: LICA 29.9, 41.5, 63.9, 64.6; RICA 30.1, 39.4, 62.6, 65.1; BA 30.0, 41.7, 66.0, 71.9; TR 31.7, 46.8, 68.9, 74.3. There was no statistically significant (p > 0.05) difference in enhancement in any of the four vessels when the 120 ml volume was delivered compared to the 100 ml volume. However, there was a statistically significant (p < 0.05) improvement in enhancement in all four vessels when 100 ml of contrast was administered compared to 75 ml.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究的目的是在其他条件相同的情况下,使用四种不同体积的造影剂对选定的颅内血管的CT增强特征进行定量评估,以帮助确定具有成本效益的剂量。以双盲、前瞻性的方式,将100例接受增强头颅CT检查的患者随机分配,使其接受四种不同体积(50、75、100或120 ml)的碘海醇(320 mg I/ml)中的一种,随后通过高压注射器以1 ml/s的速率静脉注射。还获取了平扫图像。所有患者的扫描时间、层厚和其他参数均相同。在注射完全部造影剂后立即开始扫描。使用直径为1 mm的圆圈,以标准化方式在左侧床突上段颈内动脉(LICA)、右侧床突上段颈内动脉(RICA)、基底动脉(BA)和窦汇区(TR)的造影前和造影后扫描图像上进行感兴趣区亨氏单位测量。50 ml、75 ml、100 ml和120 ml剂量组中,各血管的平均增强值(以亨氏单位计)分别如下:LICA为29.9、41.5、63.9、64.6;RICA为30.1、39.4、62.6、65.1;BA为30.0、41.7、66.0、71.9;TR为31.7、46.8、68.9、74.3。与100 ml体积相比,注射120 ml体积时,四根血管中的任何一根的增强均无统计学显著差异(p>0.05)。然而,与75 ml相比,注射100 ml造影剂时,所有四根血管的增强均有统计学显著改善(p<0.05)。(摘要截取自250字)

相似文献

1
Quantitative contrast media dose evaluation for cranial computed tomography.用于头颅计算机断层扫描的定量造影剂剂量评估
Comput Med Imaging Graph. 1995 May-Jun;19(3):287-93. doi: 10.1016/0895-6111(95)00006-c.
2
Low-osmolality contrast media: dosage comparison of ioversol and iohexol for cranial computed tomography.低渗性对比剂:碘海醇与碘克沙醇用于头颅计算机断层扫描的剂量比较
Comput Med Imaging Graph. 1991 Nov-Dec;15(6):403-6. doi: 10.1016/0895-6111(91)90166-s.
3
CT angiography of intracranial arterial vessels: impact of tube voltage and contrast media concentration on image quality.颅内动脉血管的CT血管造影:管电压和造影剂浓度对图像质量的影响。
Acta Radiol. 2012 Oct 1;53(8):929-34. doi: 10.1258/ar.2012.120218. Epub 2012 Aug 17.
4
Comparison of enhancement, image quality, cost, and adverse reactions using 2 different contrast medium concentrations for routine chest CT on 16-slice MDCT.在16层螺旋CT上使用两种不同浓度的对比剂进行常规胸部CT扫描时,对强化效果、图像质量、成本及不良反应进行比较。
J Comput Assist Tomogr. 2006 Sep-Oct;30(5):818-22. doi: 10.1097/01.rct.0000229999.30897.3b.
5
A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.碘帕醇-370与碘克沙醇-320在接受多排螺旋计算机断层扫描患者中的疗效与安全性比较。
Invest Radiol. 2007 Dec;42(12):856-61. doi: 10.1097/RLI.0b013e3181514413.
6
Optimization of low-osmolality contrast media for cranial CT: a dose comparison of two contrast agents.用于头颅CT的低渗性对比剂优化:两种对比剂的剂量比较
AJNR Am J Neuroradiol. 1990 Sep-Oct;11(5):847-9; discussion 850-1.
7
CT pulmonary angiography using a reduced volume of high-concentration iodinated contrast medium and multiphasic injection to achieve dose reduction.采用低浓度大容积碘对比剂和多期注射行 CT 肺动脉造影以减少造影剂用量。
Clin Radiol. 2014 Jan;69(1):36-40. doi: 10.1016/j.crad.2013.07.023. Epub 2013 Sep 23.
8
An observational study to evaluate the efficiency and safety of ioversol pre-filled syringes compared with ioversol bottles in contrast-enhanced examinations.一项观察性研究,旨在评估碘克沙醇预充式注射器与碘克沙醇瓶装制剂在对比增强检查中的有效性和安全性。
Acta Radiol. 2012 Oct 1;53(8):914-20. doi: 10.1258/ar.2012.120303. Epub 2012 Sep 14.
9
Dose optimization of nonionic contrast agent in dynamic computed tomography scanning of the abdomen and pelvis.腹部和盆腔动态计算机断层扫描中碘造影剂的剂量优化
Clin Imaging. 1994 Jan-Mar;18(1):72-4. doi: 10.1016/0899-7071(94)90151-1.
10
Sixteen-detector row CT angiography of carotid arteries: comparison of different volumes of contrast material with and without a bolus chaser.十六排螺旋CT颈动脉血管造影:不同造影剂用量联合或不联合团注追踪的比较
Radiology. 2005 Nov;237(2):555-62. doi: 10.1148/radiol.2372040653. Epub 2005 Sep 16.

引用本文的文献

1
Effect of contrast enhanced CT scans on heterogeneity corrected dose computations in the lung.对比增强CT扫描对肺部异质性校正剂量计算的影响。
J Appl Clin Med Phys. 2006 Nov 28;7(4):1-12. doi: 10.1120/jacmp.v7i4.2240.
2
Comparative study of vascular enhancement on post-contrast CT using three dosages of iodinated contrast media for the aim of detecting brain metastasis in patients with lung cancer.使用三种剂量的碘化造影剂进行对比增强CT血管强化的比较研究,目的是检测肺癌患者的脑转移。
Radiat Med. 2006 Feb;24(2):128-32. doi: 10.1007/BF02493279.